-+ 0.00%
-+ 0.00%
-+ 0.00%

RIGEL PRESENTS UPDATED DATA FROM THE ONGOING PHASE 1B STUDY EVALUATING R289 IN PATIENTS WITH LOWER-RISK MDS AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

Reuters·12/07/2025 14:30:03

Please log in to view news